Get the Stockscreener App
42.41
0.09%
-0.04
After Hours:
42.41
Tandem Diabetes Care Inc stock is traded at $42.41, with a volume of 1.17M.
It is down -0.09% in the last 24 hours and down -2.51% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$42.45
Open:
$42.25
24h Volume:
1.17M
Relative Volume:
0.77
Market Cap:
$2.75B
Revenue:
$796.00M
Net Income/Loss:
$-136.49M
P/E Ratio:
-13.13
EPS:
-3.23
Net Cash Flow:
$-64.24M
1W Performance:
-6.63%
1M Performance:
-2.51%
6M Performance:
+19.77%
1Y Performance:
+104.19%
1-Day Range:
$41.39
$43.21
1-Week Range:
$41.39
$47.60
52-Week Range:
$13.82
$53.69
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Tandem Diabetes' SWOT analysis: stock outlook amid Mobi success, valuation shifts - Investing.com
Automated Insulin Delivery Systems Market Analysis for Rising - openPR
Susquehanna Portfolio Strategies LLC Has $570,000 Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Health Check: How Prudently Does Tandem Diabetes Care (NASDAQ:TNDM) Use Debt? - Simply Wall St
Driehaus Capital Management LLC Has $38.49 Million Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Marshall Wace LLP Has $21.13 Million Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stake Boosted by Envestnet Asset Management Inc. - MarketBeat
State of New Jersey Common Pension Fund D Invests $1.45 Million in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU - MSN
Fred Alger Management LLC Has $87.60 Million Stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
TNDM Stock Likely to Gain From Innovation Amid Competition - MSN
First Light Asset Management LLC Grows Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Renaissance Technologies LLC Lowers Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 3.8% - MarketBeat
TNDM Stock Likely To Gain From Innovation Amid Competition - Barchart
Tandem Diabetes Care (NASDAQ:TNDM) Given Equal Weight Rating at Morgan Stanley - MarketBeat
TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU - Yahoo Finance
Analysts Set Tandem Diabetes Care, Inc. (NASDAQ:TNDM) PT at $54.36 - MarketBeat
Tandem secures approval for t:slim X2 insulin pump to use with Lyumjev - Medical Device Network
Why Tandem Diabetes Care Stock Thrashed the Market Today - Yahoo Finance
Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union - StockTitan
Tandem Diabetes Care (NASDAQ:TNDM) Trading Up 4.2% - MarketBeat
Rhumbline Advisers Raises Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Victory Capital Management Inc. Increases Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Diabetes Care Devices Market Estimated to Experience a Hike in Growth by 2028 - openPR
Nicholas Investment Partners LP Acquires New Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Capital World Investors Reduces Stake in Tandem Diabetes Care Inc - Yahoo Finance
Where are the Opportunities in (TNDM) - Stock Traders Daily
Digital Diabetes Management Market Size to Expand Lucratively by 2031 As Revealed In New Report - WhaTech
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 4.3% - MarketBeat
Chicago Capital LLC Increases Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Position Increased by Bank of New York Mellon Corp - MarketBeat
Principal Financial Group Inc. Increases Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Exploring Technological Innovations, Market Growth, and the Future of Digital Diabetes Management Market - WhaTech
Reasons to Hold Tandem Diabetes Stock in Your Portfolio Now - MSN
Stifel maintains Buy rating on Tandem Diabetes shares - Investing.com
Reasons to Hold Tandem Diabetes Stock in Your Portfolio Now - Yahoo Finance
Lisanti Capital Growth LLC Lowers Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Hanseatic Management Services Inc. Makes New Investment in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Potential Upside For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Not Without Risk - Simply Wall St
New Launches Support Tandem Diabetes Stock Despite Macro Concerns - Yahoo Finance
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Artificial Pancreas Market Growing Rapidly by 2031- Medtronic - openPR
Legato Capital Management LLC Increases Stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care Announces Upcoming Conference Participation - StockTitan
Baillie Gifford & Co. Trims Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes a new equal weight at Morgan Stanley due to competition - MSN
Tandem Diabetes Care (NASDAQ:TNDM) Coverage Initiated at Morgan Stanley - MarketBeat
Tandem Diabetes a new equal weight at Morgan Stanley due to competition (NASDAQ:TNDM) - Seeking Alpha
Tandem Diabetes shares hold buy rating at Lake Street despite market reaction - Investing.com UK
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Down to $45.71 - MarketBeat
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):